D

DMI Research | Pinellas Park, FL

Research site

(Unclaimed)

Location

6699 90th Avenue N, Pinellas Park, Florida, United States of America

Site insights

Top conditions

Top treatments

Tofacitinib

Methotrexate

Desmopressin

Oseltamivir

CP-690,550

Bococizumab

Troriluzule

BMS-986177

CK-2017357

RN316

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 31 total trials

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults with Major Depressive Disorder

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...

Enrolling

Major Depressive Disorder

Drug: SP-624

Drug: Placebo

Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder

The study's purpose its to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compu...

Enrolling

Obsessive-Compulsive Disorder

Drug: Troriluzole

Drug: Placebo

Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder

The purpose of the study is to evaluate the long term safety and tolerability of troriluzole as adjunctive therapy in subjects with obsessive compuls...

Invitation-only

Obsessive Compulsive Disorder

Drug: Troriluzole (BHV-4157)